SGMT

NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.73

-0.06 (-0.77%)

As of Jun 30, 10:27 PM ET ·

SGMT News1 articles

Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial

Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.